94 research outputs found

    Oxidation of aryl ketoximes and hydrazones with cerium (IV) salts

    Get PDF

    Do Different Breeds of Dairy Cow Differ in Their Ability to Digest Perennial Ryegrass?

    Get PDF
    Grazed grass is the cheapest feed source available for ruminant production systems in temperate climates (Finnernan et al. 2010) accounting for 70% and 90% of the diet of dairy cows in Ireland and New Zealand, respectively. Successful operation of grass-based dairy systems is based on achieving large intakes of high quality grass and efficiently converting it into high value milk solids (Prendiville et al. 2010). Prendiville et al. (2009) identified production efficiency differences between Holstein Friesian (HF) and Jersey (J) cows. They found that J had higher milk solids output per 100 kg bodyweight than HF. The aim of this study was to identify if HF, J and crossbred (J×HF) cows differ in their ability to digest perennial ryegrass

    The role of endogenous aryl hydrocarbon receptor signaling in cardiovascular physiology

    Get PDF
    The aryl hydrocarbon receptor (AHR) is an orphan nuclear receptor with a primary function of mediating xenobiotic metabolism through transcriptional activation of Phase I and Phase II drug-metabolizing enzymes. Although no high-affinity physiological activators of AHR have been discovered, the endogenous signaling of the AHR pathway is believed to play an important role in the development and function of the cardiovascular system, based on the observations on ahr gene-deficient mice. The AHR knockout mice develop cardiac hypertrophy, abnormal vascular structure in multiple organs and altered blood pressure depending on their host environment. In this review, the endogenous role of AHR in cardiovascular physiology, including heart function, vascular development and blood pressure regulation has been summarized and discussed

    Behavioural responses of pasture based dairy cows to short term management in tie-stalls

    Get PDF
    peer-reviewedDairy cows in experimental grazing herds are often confined for metabolic measurements. The objective of this study was to establish effects of transfer from pasture, to tie-stalls in a metabolism house, then back to pasture, on lying behaviour and locomotion score of lactating cows: Holstein-Friesian (H, n = 16), Jersey (J, n = 16) and H × J (HJ, n = 16). Cows were transferred to tie-stalls on d 1 for 12 days, and were offered freshly cut ryegrass according to herbage allowance (HERB) and genotype: J low = 14; J high = 17; H and HJ low = 16; and H and HJ high = 20 kg DM/d. Lying behaviour was recorded on four days: −2, −1 (Pre-confinement), 3 (Early confinement), 10, 11 (Late confinement), 13 and 14 (Post-confinement) relative to transfer (d 1) using dataloggers, and was also video-recorded during the first 15 h. Locomotion score was recorded on days −4, −3, 12 and 16. No effects of HERB on lying variables were observed during the first 15 h in confinement, but J cows made more lying intentions (21.0 vs. 12.2; P < 0.05) and tended (P = 0.07) to have a shorter latency to lie. Cows spent less (P < 0.001) time lying in early confinement (07:22:29 h/d) than on any of the other occasions (9:12:50 h/d). Cows had more (P < 0.001) and shorter (P < 0.001) lying bouts in confinement than while at pasture. Low HERB cows spent more time lying than high HERB cows (09:54:55 vs. 09:09:33 h/d; P < 0.01). J had higher locomotion scores than H (9.2 ± 0.2 vs.7.8 ± 0.2; P < 0.001), and tended (P = 0.09) to have higher scores than HJ (8.5 ± 0.2) cows. Locomotion scores were lowest pre confinement, highest at turnout (d 12), and intermediate after that at pasture (d 16) (7.6 ± 0.2, 9.3 ± 0.2 and 8.6 ± 0.3, respectively; P < 0.01). On transfer to the metabolism house cows showed disrupted patterns of lying although daily lying time returned to levels similar to pasture by late confinement. Confinement also resulted in a short-term deterioration in locomotory ability, which although improving, was still evident 4 days following the cows return to pasture with Jersey cows being more affected than the other genotypes. These findings suggest that longer adaptation periods and temporary release to loafing areas may improve both the validity of data collected and cow welfare

    Development of cordycepin formulations for preclinical and clinical studies

    Get PDF
    There is extensive literature on in vivo studies with cordycepin but these studies were generally conducted without validation of the various formulations, especially in terms of the solubility of cordycepin in the dosing vehicles used. Cordycepin is a promising drug candidate in multiple therapeutic areas and there is a growing interest in studies aimed at assessing the pharmacological activity of this compound in relevant animal disease models. It is likely that many reported in vivo studies used formulations in which cordycepin was incompletely soluble. This can potentially confound the interpretation of pharmacokinetics and efficacy results. Furthermore, the presence of particles in intravenously administered suspension can cause adverse effects and should be avoided. Here we present the results from our development of simple and readily applicable formulations of cordycepin based on quantitative solubility assessment. Homogeneous solutions of cordycepin were prepared in phosphate-buffered saline (PBS) at different pH levels, suitable as formulations for both intravenously and oral administration. For the purpose of high-dose oral administration we also developed propylene glycol (PPG)-based vehicles in which cordycepin is completely soluble. The stability of the newly developed formulations was also assessed, as well the feasibility of their sterilisation by filtration. Additionally, an HPLC-UV method for the determination of cordycepin in the formulations, which may also be useful for other purposes, was developed and validated. Our study could provide useful information for improvement of future preclinical and clinical studies involving cordycepin

    Strategies for tropical forest protection and sustainable supply chains: challenges and opportunities for alignment with the UN sustainable development goals

    Get PDF
    Governance for sustainable development increasingly involves diverse stakeholder groups, with the promise of enhanced legitimacy and effectiveness in decision-making and implementation. The UN sustainable development goals (SDGs) emphasise the important role of multiple (non-state) actors, including businesses and non-governmental organisations, including in efforts to ensure the sustainability of supply chains, and to reduce tropical deforestation and forest degradation. This paper critically analyses sustainability strategies to examine how the UN SDG agendas related to ‘sustainable supply chains’ and ‘tropical forest protection’ are framed and enacted by two contrasting non-state actors: (1) Instituto Centro de Vida (ICV), an NGO in Brazil working to address deforestation, including by supporting farmers to produce commodities, and (2) Unilever, a global consumer goods manufacturer and major buyer of such commodities. By identifying areas of variability in the discursive techniques used by ICV and Unilever, we unearth particular power dynamics that can shape the processes and outcomes of sustainability strategies. This paper finds that the two organisations use diverse strategies at different levels of governance, both participate actively in multi-stakeholder forums to advance their organisations’ goals, but have divergent framings of ‘sustainability’. Despite being considered ‘non-state’ actors, the strategies of the two organisations examined both reflect, and influence, the structural effects of the state in the implementation of non-state organisations’ strategies, and progress towards the SDGs. Although there is alignment of certain strategies related to tropical forest protection, in some cases, there is a risk that more sustainable, alternative approaches to governing forests and supply chains may be excluded

    Systemic Maternal Inflammation and Neonatal Hyperoxia Induces Remodeling and Left Ventricular Dysfunction in Mice

    Get PDF
    The impact of the neonatal environment on the development of adult cardiovascular disease is poorly understood. Systemic maternal inflammation is linked to growth retardation, preterm birth, and maturation deficits in the developing fetus. Often preterm or small-for-gestational age infants require medical interventions such as oxygen therapy. The long-term pathological consequences of medical interventions on an immature physiology remain unknown. In the present study, we hypothesized that systemic maternal inflammation and neonatal hyperoxia exposure compromise cardiac structure, resulting in LV dysfunction during adulthood.Pregnant C3H/HeN mice were injected on embryonic day 16 (E16) with LPS (80 µg/kg; i.p.) or saline. Offspring were placed in room air (RA) or 85% O(2) for 14 days and subsequently maintained in RA. Cardiac echocardiography, cardiomyocyte contractility, and molecular analyses were performed. Echocardiography revealed persistent lower left ventricular fractional shortening with greater left ventricular end systolic diameter at 8 weeks in LPS/O(2) than in saline/RA mice. Isolated cardiomyocytes from LPS/O(2) mice had slower rates of contraction and relaxation, and a slower return to baseline length than cardiomyocytes isolated from saline/RA controls. α-/β-MHC ratio was increased and Connexin-43 levels decreased in LPS/O(2) mice at 8 weeks. Nox4 was reduced between day 3 and 14 and capillary density was lower at 8 weeks of life in LPS/O(2) mice.These results demonstrate that systemic maternal inflammation combined with neonatal hyperoxia exposure induces alterations in cardiac structure and function leading to cardiac failure in adulthood and supports the importance of the intrauterine and neonatal milieu on adult health

    Left ventricular remodeling in swine after myocardial infarction: a transcriptional genomics approach

    Get PDF
    Despite the apparent appropriateness of left ventricular (LV) remodeling following myocardial infarction (MI), it poses an independent risk factor for development of heart failure. There is a paucity of studies into the molecular mechanisms of LV remodeling in large animal species. We took an unbiased molecular approach to identify candidate transcription factors (TFs) mediating the genetic reprogramming involved in post-MI LV remodeling in swine. Left ventricular tissue was collected from remote, non-infarcted myocardium, 3 weeks after MI-induction or sham-surgery. Microarray analysis identified 285 upregulated and 278 downregulated genes (FDR < 0.05). Of these differentially expressed genes, the promoter regions of the human homologs were searched for common TF binding sites (TFBS). Eighteen TFBS were overrepresented >two-fold (p < 0.01) in upregulated and 13 in downregulated genes. Left ventricular nuclear protein extracts were assayed for DNA-binding activity by protein/DNA array. Out of 345 DNA probes, 30 showed signal intensity changes >two-fold. Five TFs were identified in both TFBS and protein/DNA array analyses, which showed matching changes for COUP-TFII and glucocorticoid receptor (GR) only. Treatment of swine with the GR antagonist mifepristone after MI reduced the post-MI increase in LV mass, but LV dilation remained unaffected. Thus, using an unbiased approach to study post-MI LV remodeling in a physiologically relevant large animal model, we identified COUP-TFII and GR as potential key mediators of post-MI remodeling
    corecore